Cargando…
Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans
The MosaiQ® COVID-19 Antibody test fulfills the minimal requirements for serological testing according to the French regulation.
Autores principales: | Martinaud, Christophe, Hejl, Carine, Igert, Alexandre, Bigaillon, Christine, Bonnet, Céline, Mérens, Audrey, Wolf, Audrey, Foissaud, Vincent, Leparc-Goffart, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392856/ https://www.ncbi.nlm.nih.gov/pubmed/32750664 http://dx.doi.org/10.1016/j.jcv.2020.104571 |
Ejemplares similares
-
Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting
por: Vicario, José, et al.
Publicado: (2021) -
Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018) -
Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022) -
MONOCLONAL PRODUCTION OF BOTH IgM AND IgG1 ANTIHAPTEN ANTIBODY
por: Press, Joan L., et al.
Publicado: (1973) -
Patterns of IgG and IgM antibody response in COVID-19 patients
por: Liu, Xuemei, et al.
Publicado: (2020)